Table 2 Comparison of efficacy indexes between the two groups
Item | Combined medication group (n = 92) | Uterine curettage group (n = 92) | Z/t/χ2 value | P value | |
|---|---|---|---|---|---|
Diameter of residue | Before treatment | 15.04 ± 6.31 | 15.21 ± 6.26 | -0.113 | 0.912 |
After treatment | 0.00 | 4.26 ± 2.34 | -3.359 | 0.010* | |
Serum β-HCG level | Before treatment | 214.69 ± 52.96 | 234.51 ± 67.46 | -1.327 | 0.189 |
After treatment | 10.34 ± 3.47 | 102.45 ± 103.26 | -0.611 | 0.541* | |
Days of vaginal bleeding | 9.79 ± 1.76 | 11.92 ± 1.91 | -4.688 | < 0.001 | |
Return time of menses | 28.58 ± 2.67 | 31.24 ± 2.43 | -4.238 | < 0.001 | |
Duration of menstruation | 6.12 ± 1.12 | 5.11 ± 0.98 | -2.681 | 0.007 | |
Menstrual volume after return of menses | More than previous | 6 | 3 | 16.472 | < 0.001 |
Equal to previous | 74 | 53 | |||
Less than previous | 12 | 36 |